Physician profile
Anna P Hsu
NPI 1902023625
$1,795.71
in general payments reported to CMS, 2019-2025
14 companies · $758 in 2025
The $758 reported for 2025 was more than what 80% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.26 · 2022: $114 · 2023: $241 · 2024: $615 · 2025: $758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,614.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $799.59 | 2021-2025 | Nucala |
| Genzyme Corporation | $327.40 | 2023-2025 | |
| Neurent Medical Limited | $211.77 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Grifols USA, LLC | $123.09 | 2024-2025 | Xembify, Gamunex-C |
| Stryker Corporation | $83.33 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $53.30 | 2024 | Dupixent |
| W. L. Gore & Associates, INC. | $33.40 | 2021 | |
| Aerin Medical INC. | $31.12 | 2022 | |
| Novartis Pharmaceuticals Corporation | $27.80 | 2025 | |
| Hologic Sales and Service, LLC | $26.03 | 2024 | Coolseal Generator |
| Hikma Pharmaceuticals USA | $22.04 | 2025 | Ryaltris |
| Amgen INC. | $21.68 | 2023 | Tezspire |
| Optinose US, INC. | $19.00 | 2025 | |
| Alk-Abello, INC | $16.16 | 2023 | Ragwitek, Grastek, Odactra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.